Skip to main content

Table 1 Intervention description

From: FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients—efficacy and microbiologic safety

Groups

Interventions

Experimental group

Patients in this arm will receive study medication fosfomycin 500 mg every 8 h orally or intravenously in case of intolerance to the oral route

Control group

Ciprofloxacin 500 mg every 12 h orally or intravenously in case of intolerance to the oral route (https://clinicaltrials.gov/study/NCT01371656?term=ACCL0934&rank=1